Angi Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 3, 2026, reporting a net loss of $238,307 thousand for the first nine months of the year, driven in large part by a $225,628 thousand goodwill impairment charge.

Key Highlights

  • Revenue declined: Nine-month revenue fell to $728,171 thousand from $789,767 thousand in the same period of 2025, according to the filing.
  • Goodwill impairment: The company recorded a goodwill impairment charge of $225,628 thousand in the nine months ended September 30, 2026, with no comparable charge in the prior-year period.
  • Intangible asset impairment: An additional impairment of intangibles of $9,600 thousand was recorded in the nine-month period, the filing disclosed.
  • Net loss vs. prior-year profit: The nine-month net loss attributable to Angi Inc. shareholders was $238,307 thousand, compared to net earnings of $36,608 thousand for the same period in 2025.
  • Q3 standalone earnings: For the three months ended September 30, 2026, net earnings attributable to shareholders were $1,338 thousand, or $0.03 per basic and diluted share.
  • Total assets contracted: Total assets were $1,321,963 thousand as of September 30, 2026, down from $1,680,368 thousand as of December 31, 2025.
  • Shares outstanding: As of October 30, 2026, there were 40,961,569 total shares of common stock outstanding, all Class A.

Goodwill Impairment and Revenue Decline Weigh on Angi's Nine-Month Results

According to the filing, Angi Inc. (NASDAQ:ANGI) reported nine-month revenue of $728,171 thousand, a decrease from $789,767 thousand in the first nine months of 2025. Gross profit for the nine-month period was $696,156 thousand, compared to $751,150 thousand a year earlier. The company's cost of revenue fell to $32,015 thousand from $38,617 thousand over the same comparison period.

The most significant charge affecting the nine-month results was a goodwill impairment of $225,628 thousand, recorded during the period with no comparable amount in 2025. The filing also shows an impairment of intangibles of $9,600 thousand and restructuring charges of $16,424 thousand in the nine months ended September 30, 2026. These charges contributed to a nine-month operating loss of $227,737 thousand, compared to operating income of $59,458 thousand in the prior-year period. The accumulated deficit on the balance sheet grew to $389,187 thousand as of September 30, 2026, from $150,880 thousand as of December 31, 2025.

For the third quarter alone, the filing reported revenue of $242,018 thousand and operating income of $15,476 thousand. Selling and marketing expense for the nine-month period increased to $409,216 thousand from $387,308 thousand year-over-year, while general and administrative expense declined to $179,846 thousand from $200,810 thousand. Product development expense fell sharply to $30,595 thousand from $71,430 thousand. Total shareholders' equity as of September 30, 2026 was $698,125 thousand, down from $927,366 thousand at December 31, 2025. Cash and cash equivalents were $202,503 thousand at the end of the period, compared to $303,701 thousand at year-end 2025.

What Was Disclosed

Angi Inc. disclosed its unaudited consolidated financial results for the three and nine months ended September 30, 2026, including a large goodwill impairment, an intangible asset impairment, restructuring charges, and a nine-month net loss of $238,307 thousand, alongside a third-quarter net profit of $1,338 thousand.